Nonalcoholic fatty liver disease: an emerging driver of hypertension

YC Zhao, GJ Zhao, Z Chen, ZG She, J Cai, H Li - Hypertension, 2020 - Am Heart Assoc
Hypertension, a multifactorial disorder resulting from the interplay between genetic
predisposition and environmental risk factors, affects≈ 30% of adults. Emerging evidence …

Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases

J Cai, XJ Zhang, YX Ji, P Zhang, ZG She… - Circulation research, 2020 - Am Heart Assoc
Cardiovascular diseases (CVDs) remain a leading cause of death worldwide. Among the
major risk factors for CVD, obesity and diabetes mellitus have received considerable …

TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis

J Hou, J Zhang, P Cui, Y Zhou, C Liu… - The Journal of …, 2021 - Am Soc Clin Investig
Sepsis is a leading cause of death in critical illness, and its pathophysiology varies
depending on preexisting medical conditions. Here we identified nonalcoholic fatty liver …

Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week

A Mantovani, CD Byrne, G Benfari, S Bonapace… - Journal of the American …, 2022 - jacc.org
Heart failure (HF) and nonalcoholic fatty liver disease (NAFLD) are 2 conditions that have
become important global public health problems. Emerging evidence supports a strong and …

Nonalcoholic fatty liver disease: an emerging driver of cardiac arrhythmia

ZE Chen, J Liu, F Zhou, H Li, XJ Zhang… - Circulation …, 2021 - Am Heart Assoc
Cardiac arrhythmias and the resulting sudden cardiac death are significant cardiovascular
complications that continue to impose a heavy burden on patients and society. An emerging …

Non Alcoholic Fatty Liver Disease; Disease Burden, Management, and Future Perspectives

PJIV Paulino, KM Cuthrell… - … Research Journal of …, 2024 - archive.pcbmb.org
Non-alcoholic fatty liver disease (NAFLD) is a significant and pertinent human ailment linked
to a modified way of life, characterized by a fast increasing occurrence and prevalence in the …

Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle …

R Sandireddy, S Sakthivel, P Gupta, J Behari… - Frontiers in cell and …, 2024 - frontiersin.org
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-
alcoholic fatty liver disease (NAFLD), is the most common liver disorder worldwide, with an …

Cardiac autonomic neuropathy in obesity, the metabolic syndrome and prediabetes: a narrative review

SM Williams, A Eleftheriadou, U Alam, DJ Cuthbertson… - Diabetes Therapy, 2019 - Springer
Cardiac autonomic neuropathy (CAN) is a major complication of type 1 and type 2 diabetes
mellitus (T1DM and T2DM). The increased morbidity, cardiovascular and all-cause mortality …

Natural history of histologically proven alcohol-related liver disease: a systematic review

R Parker, GP Aithal, U Becker, D Gleeson… - Journal of …, 2019 - Elsevier
Background & Aims To date, studies into the natural history of alcohol-related liver disease
(ALD) have lacked long-term follow-up, large numbers of participants, or both. We performed …

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis

Y Tang, J Huang, WY Zhang, S Qin… - Therapeutic …, 2019 - journals.sagepub.com
Background: Nonalcoholic fatty liver disease (NAFLD) has become prevalent in recent
decades, especially in developed countries, and approaches for the prevention and …